ResMed Inc.
RMD
Key stats
- Open
- 238.78
- Day high
- 243.45
- Day low
- 237.83
- Previous close
- 238.53
- Volume
- 1.09M
- VWAP
- 240.08
- 52-week high
- 277.67
- 52-week low
- 180.27
- Market cap
- 33.55B
- Shares out
- 140.66M
- Employees
- 11,370
- Listed
- 1995
About ResMed Inc.
ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder. Growth depends on diagnosing more of the large untreated sleep apnea population and moving them onto therapy. The Americas contribute about two-thirds of device and mask revenue, with most of the rest from Europe, Japan, and Australia.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SAN DIEGO, CA · resmed.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 869
- Put open interest
- 1.2K
- Put/call
- 1.40
- At-the-money IV
- 32.5%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 210 put | 0.60 | Nov 5, 2:44 PM | 111 | 56 | 57.2% |
| 200 put | 0.20 | Nov 9, 9:56 AM | 10 | 46 | 59.7% |
| 240 call | 5.52 | Nov 12, 2:01 PM | 6 | 232 | 32.5% |
| 240 put | 3.83 | Nov 12, 2:02 PM | 6 | 264 | 31.5% |
| 210 call | 41.50 | Oct 22, 2:53 PM | 5 | 5 | 56.1% |
| 250 put | 14.03 | Nov 4, 10:38 AM | 5 | 34 | 23.3% |
Quarterly results
Massive · Oct 30, 2026| Q1 2027 to Sep 30, 2026 | Q4 2026 to Jun 30, 2026 | Q3 2026 to Mar 31, 2026 | Q2 2026 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $1.41B | $1.46B | $1.43B | $1.42B |
| Gross profit | $870.57M | $869.52M | $898.83M | $886.53M |
| Operating income | $452.98M | $448.71M | $499.81M | $491.66M |
| Net income | $418.41M | $383.43M | $398.73M | $392.59M |
| Diluted EPS | 2.92 | 2.64 | 2.74 | 2.68 |
| Operating cash flow | $422.42M | $454.63M | $554.13M | $339.75M |
| Assets | $8.21B | $8.97B | $8.78B | $8.50B |
| Liabilities | $2.26B | $2.38B | $2.29B | $2.18B |
| Equity | $5.95B | $6.59B | $6.49B | $6.32B |
Technicals
Massive · Nov 12, 2026- 50-day average231.95
- 200-day average223.96
- RSI (14 days)51.8
Short interest
Massive · Oct 30, 2026- Oct 30, 202610.47M shares · 7.0 days to cover
- Oct 15, 202611.92M shares · 12.3 days to cover
- Sep 30, 202612.78M shares · 9.9 days to cover
- Sep 15, 202614.20M shares · 11.7 days to cover
Dividends
Massive · Nov 12, 2026- Ex Nov 12, 2026, paid Dec 17, 20260.6600 · 4 a year
- Ex Aug 20, 2026, paid Sep 24, 20260.6600 · 4 a year
- Ex May 14, 2026, paid Jun 18, 20260.6000 · 4 a year
- Ex Feb 12, 2026, paid Mar 19, 20260.6000 · 4 a year
- Ex Nov 13, 2025, paid Dec 18, 20250.6000 · 4 a year
- Ex Aug 14, 2025, paid Sep 18, 20250.6000 · 4 a year
- Ex May 8, 2025, paid Jun 12, 20250.5300 · 4 a year
- Ex Feb 13, 2025, paid Mar 20, 20250.5300 · 4 a year
Splits
Massive · Aug 31, 2010- Aug 31, 20102-for-1
- Oct 3, 20052-for-1
Related companies
MassiveNews coverage
No stories about ResMed Inc. right now.